Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopes
HLA I 类限制性 HIV 衍生 CTL 表位的混杂呈现
基本信息
- 批准号:7569523
- 负责人:
- 金额:$ 40.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-15 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAnimal ModelAntigensAvidityBindingCellsCellular ImmunityCytotoxic T-LymphocytesDataDisease ProgressionEpitopesEvolutionHIVHIV InfectionsHIV vaccineHLA AntigensHost DefenseHumanImmuneImmunityKineticsLearningLeftLinkMediatingMusPeptidesPublicationsRelative (related person)ReportingSurfaceSystemT-Cell ReceptorT-Lymphocyte EpitopesTestingUpper armVariantViralViral AntigensVirus Diseasesantigen processingbaseimprovedin vivopathogenpressureresponsevaccine development
项目摘要
DESCRIPTION (provided by applicant):
Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopes CTL mediated cellular immunity is considered an important arm of the host defense against HIV infection and a number of HLA class I alleles have been associated with slow or fast HIV disease progression. Despite some significant advances in the field, the mechanisms by which HLA class I alleles mediate their beneficial or detrimental effects, are still unclear and may include multiple factors such as peptide binding, variability of targeted viral sequences, antigen processing and the kinetics of viral antigen expression. Recent data from murine studies have also linked T-cell receptor (TCR) repertoire diversity with relative control of viral infections. Comparing closely related MHC molecules presenting the identical epitope, these analyses revealed different TCR repertoire diversity depending on which MHC allele presented the targeted epitope and indicated that a narrow TCR repertoire was associated with CTL responses of low functional avidity and inability to control viral replication. Based on these recent reports and our own, extensive preliminary recent data, the present proposal aims to identify HIV encoded, promiscuously binding CTL epitopes that can be presented by HLA alleles differentially associated with HIV disease progression and to assess the functional avidity and TCR repertoire diversity of these CTL responses, depending on which allele the epitope is presented. Functional avidity and TCR repertoire diversity are then put in relation with the CTL's ability to efficiently recognize naturally occurring viral epitope variants and to drive viral evolution in response to immune selection pressure mediated by epitope presentation on alleles associated with wither fast or slow disease progression. Focusing on promiscuously binding CTL epitopes, the potential association between TCR repertoire diversity, functional avidity and rate of HIV disease progression can be assessed in the absence of a number of confounding effects that have limited similar analyses in the past. The emerging data will be of significant importance for HIV vaccine development and help the identification of true immune correlates of protective HIV immunity.
描述(由申请人提供):
CTL介导的细胞免疫被认为是宿主防御HIV感染的重要手段,并且许多HLA I类等位基因与缓慢或快速的HIV疾病进展相关。尽管在该领域取得了一些重大进展,但HLA I类等位基因介导其有益或有害作用的机制仍不清楚,可能包括多种因素,如肽结合、靶向病毒序列的变异性、抗原加工和病毒抗原表达的动力学。最近的鼠研究数据也将T细胞受体(TCR)库多样性与病毒感染的相对控制联系起来。比较呈现相同表位的密切相关的MHC分子,这些分析揭示了不同的TCR库多样性,这取决于哪个MHC等位基因呈现靶向表位,并表明窄的TCR库与低功能亲合力和不能控制病毒复制的CTL应答相关。基于这些最近的报告和我们自己的,广泛的初步最近的数据,本提案的目的是确定HIV编码的,混杂结合的CTL表位,可以提出的HLA等位基因差异与HIV疾病的进展,并评估这些CTL反应的功能亲合力和TCR库的多样性,这取决于哪个等位基因的表位。然后将功能亲合力和TCR库多样性与CTL有效识别天然存在的病毒表位变体的能力以及响应于由与枯萎快速或缓慢疾病进展相关的等位基因上的表位呈递介导的免疫选择压力而驱动病毒进化的能力相关联。聚焦于混杂结合的CTL表位,TCR库多样性、功能亲合力和HIV疾病进展速率之间的潜在关联可以在不存在许多混淆效应的情况下进行评估,这些混淆效应限制了过去的类似分析。新出现的数据将对HIV疫苗开发具有重要意义,并有助于识别保护性HIV免疫的真正免疫相关性。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel E Kaufmann其他文献
A high dimensional immune monitoring model of HIV-specific CD8 T cell responses accurately identifies subjects achieving spontaneous control of viral replication
- DOI:
10.1186/1742-4690-9-s1-p19 - 发表时间:
2012-05-25 - 期刊:
- 影响因子:3.900
- 作者:
Zaza M Ndhlovu;Lori B Chibnik;Jacqueline Proudfoot;Seanna Vine;Ashley McMullen;Kevin Cesa;Donna Marie Alvino;Alicja Piechocka-Trocha;Philip L de Jager;Daniel E Kaufmann;Bruce D Walker - 通讯作者:
Bruce D Walker
Tumor-necrosis factor is a master of T cell exhaustion
肿瘤坏死因子是 T 细胞衰竭的主宰
- DOI:
10.1038/ni.3436 - 发表时间:
2016-04-19 - 期刊:
- 影响因子:27.600
- 作者:
Amy E Baxter;Daniel E Kaufmann - 通讯作者:
Daniel E Kaufmann
Daniel E Kaufmann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel E Kaufmann', 18)}}的其他基金
Immunoregulatory networks and HIV pathogenesis
免疫调节网络和艾滋病毒发病机制
- 批准号:
8115205 - 财政年份:2007
- 资助金额:
$ 40.69万 - 项目类别:
Immunoregulatory networks and HIV pathogenesis
免疫调节网络和艾滋病毒发病机制
- 批准号:
8515500 - 财政年份:2007
- 资助金额:
$ 40.69万 - 项目类别:
Immunoregulatory networks and HIV pathogenesis
免疫调节网络和艾滋病毒发病机制
- 批准号:
8714024 - 财政年份:2007
- 资助金额:
$ 40.69万 - 项目类别:
Immunoregulatory networks and HIV pathogenesis
免疫调节网络和艾滋病毒发病机制
- 批准号:
7339459 - 财政年份:2007
- 资助金额:
$ 40.69万 - 项目类别:
Immunoregulatory networks and HIV pathogenesis
免疫调节网络和艾滋病毒发病机制
- 批准号:
8410266 - 财政年份:2007
- 资助金额:
$ 40.69万 - 项目类别:
Immunoregulatory networks and HIV pathogenesis
免疫调节网络和艾滋病毒发病机制
- 批准号:
8896017 - 财政年份:2007
- 资助金额:
$ 40.69万 - 项目类别:
Immunoregulatory networks and HIV pathogenesis
免疫调节网络和艾滋病毒发病机制
- 批准号:
7683973 - 财政年份:2007
- 资助金额:
$ 40.69万 - 项目类别:
Immunoregulatory networks and HIV pathogenesis
免疫调节网络和艾滋病毒发病机制
- 批准号:
7923158 - 财政年份:2007
- 资助金额:
$ 40.69万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 40.69万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 40.69万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 40.69万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 40.69万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 40.69万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 40.69万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 40.69万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 40.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 40.69万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 40.69万 - 项目类别:














{{item.name}}会员




